Potential of Desert Medicinal Plants for Combating Resistant Biofilms in Urinary Tract Infections

Appl Biochem Biotechnol. 2023 Sep;195(9):5568-5582. doi: 10.1007/s12010-022-03950-4. Epub 2022 Jun 6.

Abstract

Urinary tract infections (UTIs) are among the most prevalent bacterial infections worldwide, with 11% of the global population getting infected every year. These infections are largely attributed to quorum sensing (QS)-dependent ability of pathogens to form biofilms in the urinary tract. Antimicrobial resistance is increasing, and the use of antimicrobial medicines in the future is yet uncertain. The desert medicinal plants have great potential to treat several diseases as per the available ethnobotanical database. Some of these plants have been used in folklore medicines to treat urinary tract infections also. There are many bioactive compounds derived from these desert medicinal plants that have been documented to possess antimicrobial as well as antibiofilm activity against uropathogens. The minimum biofilm inhibitory concentration (MBIC) of these plant extracts have been reported in the range of 31.5-250 μg/mL. The rising prevalence of drug-resistant diseases necessitates standardised modern analytical technologies to detect and isolate novel bioactive compounds from medicinal plants. This review seeks to combine the studies of desert plants with antimicrobial and anti-quorum sensing properties, supporting their sustainable use in treatment of urinary tract infections.

Keywords: Antimicrobial; Biofilm; Desert medicinal plants; Quorum sensing; Urinary tract infections.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents* / pharmacology
  • Biofilms
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Plants, Medicinal*
  • Quorum Sensing
  • Urinary Tract Infections* / drug therapy

Substances

  • Plant Extracts
  • Anti-Infective Agents
  • Anti-Bacterial Agents